MicroRNAs as Potential Biomarkers for the Diagnosis of Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Authors:
Open Access
- 7 February 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8, 782561
Abstract
For Chronic Kidney Disease (CKD), the study of microRNA as a biomarker has become an exciting area, so we carried out a meta-analysis to investigate the potential diagnostic values of miRNAs in CKD. We searched Pubmed, Cochrane Library, Embase, and Web of science databases to identify relevant publications published from the establishment of the database to April 30, 2021. We included a total of 26 articles containing 56 studies. There were 4,098 patients with CKD and 2,450 patients without CKD. We found that the overall sensitivity and specificity of miRNAs in CKD diagnosis were 0.86 (95% CI: 0.83–0.89) and 0.79 (95% CI: 0.75–0.83), respectively. In addition, we plotted the summary receiver operator characteristic (SROC) curve to assess diagnostic accuracy, with the area under the curve (AUC) of 0.90 (95% CI: 0.87–0.92). Subgroup analysis showed that sensitivity, specificity, and AUC of miRNAs in plasma and serum were 0.84, 0.78, 0.88; and 0.79, 0.76, 0.83, respectively, while miRNAs in urine were 0.89 for sensitivity, 0.82 for specificity, and 0.92 for AUC. Moreover, we found that the panel of microRNAs (miRNAs) could improve the pooled sensitivity (0.88, 0.81, and 0.91 for sensitivity, specificity, and AUC, respectively). We believe that miRNAs have great potential to become an effective diagnostic biomarker for CKD. Panels of miRNA have higher accuracy than single miRNAs. Additionally, miRNAs in both blood and urine have significant accuracy in the diagnosis of CKD; nevertheless, urine is superior.Keywords
Funding Information
- National Key Research and Development Program of China
- National Natural Science Foundation of China
This publication has 46 references indexed in Scilit:
- MicroRNAs in kidney physiology and diseaseNature Reviews Nephrology, 2014
- Inhibition of miRNA-21 prevents fibrogenic activation in podocytes and tubular cells in IgA nephropathyBiochemical and Biophysical Research Communications, 2014
- Urine MicroRNA as Potential Biomarkers of Autosomal Dominant Polycystic Kidney Disease Progression: Description of miRNA Profiles at BaselinePLOS ONE, 2014
- MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosisAmerican Journal of Physiology-Renal Physiology, 2013
- Evolving importance of kidney disease: from subspecialty to global health burdenThe Lancet, 2013
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice GuidelineAnnals of Internal Medicine, 2013
- Chapter 1: Definition and classification of CKDKidney International Supplements, 2013
- Smad3-Mediated Upregulation of miR-21 Promotes Renal FibrosisJournal of the American Society of Nephrology, 2011
- Identification of a microRNA signature of renal ischemia reperfusion injuryProceedings of the National Academy of Sciences, 2010
- Early recognition and prevention of chronic kidney diseaseThe Lancet, 2010